Related Experiment Video
Updated: Feb 28, 2026

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
Published on: January 7, 2018
Association of chronic hypertension with birth of small-for-gestational-age neonate
A M Panaitescu1, A A Baschat2, R Akolekar1,3
1Department of Fetal Medicine, King's College Hospital, London, UK.
Insights
Chronic hypertension (CH) significantly increases the risk of small-for-gestational-age (SGA) neonates, particularly when pre-eclampsia (PE) is absent. Mean arterial pressure in early pregnancy is a key factor in this association.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Perinatology
Background:
- Chronic hypertension (CH) is a common complication of pregnancy.
- The impact of CH, with or without superimposed pre-eclampsia (PE), on fetal growth requires further elucidation.
- Understanding the mechanisms linking CH to adverse pregnancy outcomes is crucial for improved management.
Purpose of the Study:
- To investigate the association between chronic hypertension (CH) and the incidence of small-for-gestational-age (SGA) neonates.
- To determine if superimposed pre-eclampsia (PE) modifies this association.
- To explore the role of mean arterial pressure (MAP) in mediating these effects.
Main Methods:
- Prospective screening of 74,226 singleton pregnancies at 11-13 weeks' gestation.
- Recording maternal characteristics, medical history, and mean arterial pressure (MAP).
- Comparing birth-weight Z-scores and SGA incidence between women with and without CH, stratified by PE status; regression analysis used to assess MAP's impact.
Main Results:
- In pregnancies without PE, CH doubled the incidence of SGA compared to normotensive pregnancies.
- In pregnancies with PE, no significant difference in SGA incidence or birth-weight Z-score was observed between CH and non-CH groups.
- Elevated MAP at 11-13 weeks' gestation was significantly associated with increased SGA and PE risk, more pronounced in women with CH.
Conclusions:
- Chronic hypertension (CH) is linked to a higher risk of small-for-gestational-age (SGA) neonates and pre-eclampsia (PE).
- This association is mediated by mean arterial pressure (MAP) measured in early pregnancy (11-13 weeks' gestation).
- MAP measurement in early pregnancy may aid in identifying pregnancies at risk for SGA and PE in women with CH.
Objective:
To examine the effect of chronic hypertension (CH), with and without superimposed pre-eclampsia (PE), on the incidence of a small-for-gestational-age (SGA) neonate and to explore the possible mechanism for such association.
Methods:
Data for this study were derived from prospective screening for adverse pregnancy outcomes in women with singleton pregnancy attending their first routine hospital visit at 11-13 weeks' gestation, which included recording of maternal characteristics and medical history and measurement of mean arterial pressure (MAP). Birth-weight Z-score, adjusted for gestational age and maternal and pregnancy characteristics, and incidence of SGA were compared between those with and those without CH in the total population and in the subgroups of pregnancies with and without PE. Regression analysis was used to examine the relationship between MAP and birth-weight Z-score and incidence of SGA and PE in those with and those without CH.
Results:
The study population constituted 74 226 pregnancies, including 1052 (1.4%) with CH and 73 174 without CH. PE developed in 233 (22.1%) cases of the group with CH and in 1662 (2.3%) of those without CH. In the group that developed PE, there was no significant difference for either median birth-weight Z-score or incidence of SGA between those with CH and those without CH. In the group without PE, the incidence of SGA was twice as high in those with CH than in those without. There was a significant association between log10 MAP multiples of the median and incidence of SGA and PE, which was more marked in those with CH than in those without.
Conclusion:
CH is associated with an increased risk of SGA and PE and this is related to MAP at 11-13 weeks' gestation. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
Related Concept Videos
Teratogenicity
Hypertension I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Measurement of Blood Pressure
Hypertension II: Pathophysiology

